XTX Topco’s Rocket Pharmaceuticals RCKT Stock Holding History

XTX Topco’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$637K	Buy	178,027 +31,627	+22%	+$126K	0.01%	1801
2025 Q4	$514K	Sell	146,400 -1,101	-0.7%	-$3.77K	0.01%	1577
2025 Q3	$481K	Buy	147,501 +13,056	+10%	+$41.1K	0.03%	1105
2025 Q2	$329K	Buy	134,445 +100,038	+291%	+$507K	0.01%	1363
2025 Q1	$229K	Sell	34,407 -29,227	-46%	-$289K	0.01%	1602
2024 Q4	$800K	Buy	63,634 +48,131	+310%	+$725K	0.07%	423
2024 Q3	$286K	Buy	+15,503	New	+$318K	0.02%	1219
2024 Q2	–	Sell	-9,507	Closed	-$256K	–	2366
2024 Q1	$256K	Buy	+9,507	New	+$270K	0.03%	983
2023 Q1	–	Sell	-19,859	Closed	-$389K	–	1594
2022 Q4	$389K	Buy	19,859 +2,746	+16%	+$50.6K	0.08%	424
2022 Q3	$273K	Buy	+17,113	New	+$267K	0.07%	572

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Citigroup New York $157B AUM 32.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return